Fig. 11From: Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinomaPrediction of drug sensitivity on immunosuppressors of IRLPs subgroups a methotrexate, b parthenolide, c rapamycinBack to article page